5012 V (Phenobarbital 32.4 mg)
Pill imprint 5012 V has been identified as Phenobarbital 32.4 mg.
Phenobarbital is used in the treatment of sedation; seizures; hyperbilirubinemia; insomnia and belongs to the drug classes barbiturate anticonvulsants, barbiturates. There is positive evidence of human fetal risk during pregnancy. Phenobarbital 32.4 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
- 5012 V
- 32.4 mg
- Prescription only
- Drug Class:
- Barbiturate anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- 4 - Some potential for abuse
- Qualitest Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
sodium starch glycolate type A potato
|NDC Code||Manufacturer / Repackager|
|63739-0201||McKesson Packaging Services|
|67544-0057||Prepak Systems Inc (repackager)|
|55289-0535||PDRX Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about phenobarbital
- Other brands: Luminal
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.